CNRS UMR5237, Centre de Recherche en Biochimie Macromoléculaire, Montpellier, France.
PLoS One. 2012;7(2):e31815. doi: 10.1371/journal.pone.0031815. Epub 2012 Feb 20.
Mitochondrial dysfunction due to nuclear or mitochondrial DNA alterations contributes to multiple diseases such as metabolic myopathies, neurodegenerative disorders, diabetes and cancer. Nevertheless, to date, only half of the estimated 1,500 mitochondrial proteins has been identified, and the function of most of these proteins remains to be determined. Here, we characterize the function of M19, a novel mitochondrial nucleoid protein, in muscle and pancreatic β-cells. We have identified a 13-long amino acid sequence located at the N-terminus of M19 that targets the protein to mitochondria. Furthermore, using RNA interference and over-expression strategies, we demonstrate that M19 modulates mitochondrial oxygen consumption and ATP production, and could therefore regulate the respiratory chain activity. In an effort to determine whether M19 could play a role in the regulation of various cell activities, we show that this nucleoid protein, probably through its modulation of mitochondrial ATP production, acts on late muscle differentiation in myogenic C2C12 cells, and plays a permissive role on insulin secretion under basal glucose conditions in INS-1 pancreatic β-cells. Our results are therefore establishing a functional link between a mitochondrial nucleoid protein and the modulation of respiratory chain activities leading to the regulation of major cellular processes such as myogenesis and insulin secretion.
由于核或线粒体 DNA 改变导致的线粒体功能障碍导致多种疾病,如代谢性肌病、神经退行性疾病、糖尿病和癌症。然而,迄今为止,估计的 1500 种线粒体蛋白中只有一半被鉴定出来,而且这些蛋白的大多数功能仍有待确定。在这里,我们研究了一种新的线粒体类核蛋白 M19 在肌肉和胰腺β细胞中的功能。我们已经确定了 M19 的 N 端有一个 13 个氨基酸长的序列,该序列将蛋白质靶向线粒体。此外,通过 RNA 干扰和过表达策略,我们证明 M19 调节线粒体耗氧量和 ATP 产生,因此可以调节呼吸链活性。为了确定 M19 是否可以在调节各种细胞活动中发挥作用,我们表明这种类核蛋白可能通过调节线粒体 ATP 产生,在成肌细胞 C2C12 中作用于肌肉的晚期分化,并在基础葡萄糖条件下对 INS-1 胰腺β细胞的胰岛素分泌起许可作用。我们的研究结果因此建立了一种线粒体类核蛋白与呼吸链活性调节之间的功能联系,导致对肌肉生成和胰岛素分泌等主要细胞过程的调节。